Weifang Shan

972 total citations
13 papers, 338 citations indexed

About

Weifang Shan is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weifang Shan has authored 13 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weifang Shan's work include Hormonal and reproductive studies (4 papers), Estrogen and related hormone effects (4 papers) and Cancer-related Molecular Pathways (3 papers). Weifang Shan is often cited by papers focused on Hormonal and reproductive studies (4 papers), Estrogen and related hormone effects (4 papers) and Cancer-related Molecular Pathways (3 papers). Weifang Shan collaborates with scholars based in United States, Germany and Sweden. Weifang Shan's co-authors include John S. Sack, Aaron Balog, John S. Tokarski, Janet G. Mulheron, Raj N. Misra, David B. Rawlins, Hai-yun Xiao, Kevin R. Webster, S. David Kimball and Ricardo M. Attar and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and The Journal of Organic Chemistry.

In The Last Decade

Weifang Shan

13 papers receiving 328 citations

Peers

Countries citing papers authored by Weifang Shan

Since Specialization

Citations

This map shows the geographic impact of Weifang Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifang Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifang Shan more than expected).

Fields of papers citing papers by Weifang Shan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifang Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifang Shan. The network helps show where Weifang Shan may publish in the future.

Co-authorship network of co-authors of Weifang Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Weifang Shan. A scholar is included among the top collaborators of Weifang Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifang Shan. Weifang Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·David Williams, Jay A. Markwalder, Aaron Balog, Bin Chen, Libing Chen, (unknown), (unknown), Amy C. Hart, Sunil K. Mandal, (unknown), Weifang Shan, Gregory D. Vite, Kelly L. Covello, John T. Hunt, Maria Jure–Kunkel, Steven P. Seitz	15
2	[2.2.1]-Bicyclic sultams as potent androgen receptor antagonists 2016 ·Bioorganic & Medicinal Chemistry Letters ·Weifang Shan, Aaron Balog, (unknown), Xiao Zhu, Jing Chen, Mary Ellen Cvijic, Jieping Geng, Cheryl A. Rizzo, Thomas Spires, Ricardo M. Attar, Mary T. Obermeier, Sarah C. Traeger, Jun Dai, Yingru Zhang, Michael A. Galella, George L. Trainor, Gregory D. Vite, Ashvinikumar V. Gavai	11
3	Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies 2014 ·Journal of the American Chemical Society ·Patrick J. McEnaney, Kelly Fitzgerald, Andrew X. Zhang, Eugene F. Douglass, Weifang Shan, Aaron Balog, Mariya D. Kolesnikova, David A. Spiegel	36
4	Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer 2009 ·Cancer Research ·Ricardo M. Attar, Maria Jure–Kunkel, Aaron Balog, Mary Ellen Cvijic, (unknown), Cheryl A. Rizzo, Liang Schweizer, Thomas Spires, J. Suso Platero, Mary T. Obermeier, Weifang Shan, Mark Salvati, William R. Foster, Joseph Dinchuk, Shen-Jue Chen, Gregory D. Vite, Robert A. Kramer, Marco M. Gottardis	38
5	Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Mark Salvati, Aaron Balog, Weifang Shan, (unknown), (unknown), (unknown), (unknown), Gregory D. Vite, Ricardo M. Attar, Maria Jure–Kunkel, Jieping Geng, Cheryl A. Rizzo, Marco M. Gottardis, Stanley R. Krystek, Jack Z. Gougoutas, Michael A. Galella, Mary T. Obermeier, Aberra Fura, Gamini Chandrasena	20
6	The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Aaron Balog, Mark Salvati, Weifang Shan, Arvind Mathur, Leslie Leith, Donna Wei, Ricardo M. Attar, Jieping Geng, Cheryl A. Rizzo, Chihuei Wang, Stanley R. Krystek, John S. Tokarski, John T. Hunt, Marco M. Gottardis, Roberto Weinmann	25
7	Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Mark Salvati, Aaron Balog, Weifang Shan, Donna Wei, (unknown), Ricardo M. Attar, Jieping Geng, Cheryl A. Rizzo, Marco M. Gottardis, Roberto Weinmann, Stanley R. Krystek, John S. Sack, Yongmi An, Kevin Kish	48
8	1H-Pyrazolo[3,4-b]pyridine Inhibitors of Cyclin-Dependent Kinases 2003 ·Bioorganic & Medicinal Chemistry Letters ·Raj N. Misra, David B. Rawlins, Hai-yun Xiao, Weifang Shan, Isia Bursuker, (unknown), Janet G. Mulheron, John S. Sack, John S. Tokarski, S. David Kimball, Kevin R. Webster	55
9	1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-Difluorophenacyl analogues 2003 ·Bioorganic & Medicinal Chemistry Letters ·Raj N. Misra, Hai-yun Xiao, David B. Rawlins, Weifang Shan, Kristen A. Kellar, Janet G. Mulheron, John S. Sack, John S. Tokarski, S. David Kimball, Kevin R. Webster	63
10	1H‐Pyrazolo[3,4‐b]pyridine Inhibitors of Cyclin‐Dependent Kinases: Highly Potent 2,6‐Difluorophenacyl Analogues. 2003 ·ChemInform ·Raj N. Misra, Hai‐Yun Xiao, David B. Rawlins, Weifang Shan, Kristen A. Kellar, Janet G. Mulheron, John S. Sack, John S. Tokarski, S. David Kimball, Kevin R. Webster	1
11	cis-2,5-Disubstituted tetrahydrofurans from pyranosides: A novel example of remote stereocontrol by the aglycone 1995 ·Tetrahedron Letters ·Huiping Zhang, (unknown), Weifang Shan, Zheming Ruan, David R. Mootoo	9
12	A Novel Strategy for the Preparation of Substituted Tetrahydrofurans Based on Neighboring Group Participation by the Ring Oxygen of Monosaccharides 1994 ·Journal of Carbohydrate Chemistry ·(unknown), Weifang Shan, David R. Mootoo	9
13	1,2-O-Isopropylidenefuranose Templates for the Synthesis of Complex Cyclic Ethers via Neighboring Group Participation by the Acetal Ring Oxygen 1994 ·The Journal of Organic Chemistry ·Weifang Shan, (unknown), Liang Wei, David R. Mootoo	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact